{
    "organizations": [],
    "uuid": "7d180e0130cf8c017b92aca9111aea996b943877",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-genfit-official-launch-of-nash-ped/brief-genfit-official-launch-of-nash-pediatric-program-in-us-idUSASM000IDZ",
    "ord_in_thread": 0,
    "title": "BRIEF-Genfit: Official Launch Of NASH Pediatric Program In US",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 23 (Reuters) - GENFIT SA:\n* REG-GENFIT: OFFICIAL LAUNCH OF THE NASH PEDIATRIC PROGRAM, FOLLOWING PIP AND PSP AGREEMENT BY EMA AND FDA\n* ‍FDA AGREES WITH ELAFIBRANOR‘S INITIAL PSP FOR LAUNCH OF NASH PEDIATRIC CLINICAL TRIAL IN US\n* ‍PHASE 2B DATA SUPPORTIVE OF ELAFIBRANOR‘S POTENTIAL BENEFIT IN NASH PEDIATRIC POPULATION​\n* PSP AGREEMENT BY FDA CONSISTENT WITH PIP (PEDIATRIC INVESTIGATION PLAN) AGREEMENT BY EMA (EUROPEAN MEDICINES AGENCY)\n* ‍DOSE RANGING STUDY TO START IN COMING WEEKS, ON YOUNG NASH PATIENTS LIVING IN US (8-17 YEARS OLD)​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-01-23T15:47:00.000+02:00",
    "crawled": "2018-01-24T15:52:57.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "genfit",
        "sa",
        "official",
        "launch",
        "nash",
        "pediatric",
        "program",
        "following",
        "pip",
        "psp",
        "agreement",
        "ema",
        "fda",
        "agrees",
        "elafibranor",
        "initial",
        "psp",
        "launch",
        "nash",
        "pediatric",
        "clinical",
        "trial",
        "u",
        "2b",
        "data",
        "supportive",
        "elafibranor",
        "potential",
        "benefit",
        "nash",
        "pediatric",
        "psp",
        "agreement",
        "fda",
        "consistent",
        "pip",
        "pediatric",
        "investigation",
        "plan",
        "agreement",
        "ema",
        "european",
        "medicine",
        "agency",
        "ranging",
        "study",
        "start",
        "coming",
        "week",
        "young",
        "nash",
        "patient",
        "living",
        "u",
        "year",
        "old",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}